FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTC/BB: VYTR) today announced that on April 6, 2011, the Company closed on its previously announced agreement to merge with MediSync BioServices, Inc., now a wholly owned subsidiary of Vyteris focused on the potential consolidation of high-value, niche contract research organizations (CRO), site management organizations (SMO) and related businesses within the $22 billion CRO industry.1
